Efficiency Optimization of the Selection Period in Therapeutic Trials
- 1 July 1997
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 50 (7) , 793-800
- https://doi.org/10.1016/s0895-4356(97)00069-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarctionThe American Journal of Cardiology, 1993
- A coronary primary prevention study of Scottish men aged 45?64 years: Trial designJournal of Clinical Epidemiology, 1992
- Comparison of recruitment strategies for a large-scale clinical trial in the elderlyJournal of Clinical Epidemiology, 1991
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- Key learnings from the STOP-Hypertension study: An update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderlyCardiovascular Drugs and Therapy, 1991
- The qualification periodJournal of Clinical Epidemiology, 1991
- FLUCTUATING SERUM CHOLESTEROL: IMPLICATIONS FOR CORONARY PREVENTIONThe Lancet, 1988
- Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT)Controlled Clinical Trials, 1987
- Importance of time interval between repeated measurements of total or high-density lipoprotein cholesterol when estimating an individual's baseline concentrations.Clinical Chemistry, 1987
- Some effects of within-person variability in epidemiological studiesJournal of Chronic Diseases, 1973